Innovation and Antibiotic Use within Antibiotic Classes: Market Incentives and Economic Instruments
2017
Herrmann, Markus | Nkuiya, Bruno | Dussault, Anne-Renée
We analyze a monopolist’s incentive to innovate a new antibiotic which is connected to the same pool of antibiotic treatment efficacy as is another drug produced by a generic industry. We outline the differences of antibiotic use under market conditions and in the social optimum. A time and state-dependent tax-subsidy mechanism is proposed to induce the monopolist and generic industry to exploit antibiotic efficacy optimally.
Afficher plus [+] Moins [-]Informations bibliographiques
Cette notice bibliographique a été fournie par University of Minnesota
Découvrez la collection de ce fournisseur de données dans AGRIS
